It is noteworthy that the level of tau polyamination modification was not directly examined in the above in vivo studies, highlighting the need for further research to clarify the role of tau polyamination and its relationship to pathogenic tau species in animal models of tauopathy. The gene discussed is MAPT; the disease is tauopathy.